Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Covetrus (CVET) stocks in Canada
Learn how to easily invest in Covetrus stocks.
Covetrus is a health information services business based in the US. Covetrus stocks (CVET.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $25.52 – an increase of 1.7% over the previous week. Covetrus employs 5,275 staff and has a trailing 12-month revenue of around $4.6 billion.
How to buy shares in Covetrus
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CVET – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Covetrus?
- Has coronavirus impacted Covetrus shares?
- Covetrus shares summary
- Compare share dealing platforms
- Is Covetrus stock a buy or sell?
- Covetrus performance over time
- Are Covetrus shares over-valued?
- Covetrus's financials
- How volatile are Covetrus shares?
- Does Covetrus pay a dividend?
- Other common questions
Covetrus stock price (NASDAQ:CVET)Use our graph to track the performance of CVET stocks over time.
Covetrus shares at a glance
|Latest market close||$16.78|
|52-week range||$15.80 - $40.78|
|50-day moving average||$18.32|
|200-day moving average||$22.92|
|Wall St. target price||$26.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.41|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Covetrus stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Covetrus price performance over time
|1 week (2022-01-14)||3.13%|
|1 month (2021-12-21)||-8.21%|
|3 months (2021-10-21)||-17.34%|
|6 months (2021-07-21)||-33.52%|
|1 year (2021-01-21)||-57.49%|
|2 years (2020-01-21)||11.35%|
|3 years (2019-01-17)||N/A|
|5 years (2017-01-17)||N/A|
Is Covetrus under- or over-valued?
Valuing Covetrus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Covetrus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Covetrus's PEG ratio
Covetrus's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3326. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Covetrus's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Covetrus's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $158 million.
The EBITDA is a measure of a Covetrus's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$4.6 billion|
|Gross profit TTM||$798 million|
|Return on assets TTM||-0.22%|
|Return on equity TTM||-3.55%|
|Market capitalisation||$2.2 billion|
TTM: trailing 12 months
Covetrus share dividends
We're not expecting Covetrus to pay a dividend over the next 12 months.
Covetrus share price volatility
Over the last 12 months, Covetrus's shares have ranged in value from as little as $15.8 up to $40.775. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Covetrus's is 2.1112. This would suggest that Covetrus's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Covetrus, Inc. , together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that include, inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific.
Stocks similar to Covetrus
Covetrus in the news
Dudley & Shanley, Inc. Buys Amphenol Corp, Visa Inc, Ryan Specialty Group Holdings Inc, ...
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Frequently asked questions
More on investing
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.Read more…
Review the benefits and risks of investing in these tech-focused ETFs.Read more…
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.